{"name":"InnoCare Pharma Inc.","slug":"innocare-pharma-inc","ticker":"","exchange":"","domain":"innocarepharma.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxQR3JBRWhuVUZfVFVUREZMcmJROWZ4MUR4RWMxMEdudVJVVlhhMzgzRXB0Tm8tdkJid1BOX0h1Ty1lMVdzbHJ6LUk4SFZQRzRWRlBMb1piUm1ncXEweGdJTjE2QjJSLXkzWnJCQTY5OUV2RWVvbW5HdEdpRENheUlqM3ZXamhHanlEc1dNc1JqYWVUbjRROVJEQng2R3VJSGtmbXFoVjlSNm5fSE9ZRWZ3eFpMM1RGWHR4MHdabmxERm5HN3BIbHNTT2lNY1M5bHdLUmNzSGRlUEdOVm1ZeUFDd21nRHNlMEFzaTd0Rg?oc=5","date":"2026-03-26","type":"earnings","source":"The Globe and Mail","summary":"InnoCare Pharma Swings to Profit on Surging Drug Sales and Licensing Revenue - The Globe and Mail","headline":"InnoCare Pharma Swings to Profit on Surging Drug Sales and Licensing Revenue","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxPWnM1cVptRUhIejgteTc0cWhid2pJT0xCaDEzUFp1ZEJqMlU4V05saGhfWmlodmVVMUhCX2xCX19ybVVMaUNoaGhXS2FIN2FfN2t1QnZ2ay1yRVdWYXVwY1ZGN2MxbkVkb1FpeGdpRkVPNDBWakhxb1o3TVJUTnlkajBKZWhjQjJWamxfY29aNnZmVDBINDljdHZ5emI0b1JvWjROdkZOSUN0cTlOQl94Z3dnWWpOdjN4d3NxQnVsSEt2TXBQTWpwZkJOUGJFZDhIb1E3aks3YnZIZXZiZ0tlcm1xUVpoLW95?oc=5","date":"2026-03-26","type":"pipeline","source":"The Globe and Mail","summary":"InnoCare Pharma Adjusts Internal Allocation of STAR Market Share Proceeds - The Globe and Mail","headline":"InnoCare Pharma Adjusts Internal Allocation of STAR Market Share Proceeds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQRVctdUJBek91WUExczRkaHllS2Y1M09PSUtYNDF1X0UwN2lpZGZxVkJ0aHdYeEYzQnJRd1NwT09xMGVsdDEwWVMwd2N6ZHM4akdBNW1ya3YwcDB4Rkh3S3FTalF3azdwUE1VWi1tOC1RRU1fR1U1Q1VKYmdlQnIyTTdLYjhPUXFyNHNMNFRXQlkxQmNUQVVJdW16RzFkQU91azJUSHc1czNFTEozMUxMemRUWTM?oc=5","date":"2026-03-25","type":"pipeline","source":"TipRanks","summary":"InnoCare Pharma Updates Company Secretary and Governance Roles - TipRanks","headline":"InnoCare Pharma Updates Company Secretary and Governance Roles","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxORjhveFB0Z2ttQ25jY21vOVhUdHdDM0N6SXJaSEN5cWxqMEY4dG5LbVQyT3FFNTF6WGRCZ29ocDIyTG5KSXNsNzJPaDdBbl83RTZsZ2lWYVNneEdQOE1kWVBHblFhRlBwMFM5cGU3Zm9fUlBfeWNyRWVCUjdpUG9CWFFhWUZTRDZ6aV9IY2NIblFEUQ?oc=5","date":"2026-03-19","type":"pipeline","source":"BioWorld News","summary":"Innocare presents new VAV1 degradation inducers - BioWorld News","headline":"Innocare presents new VAV1 degradation inducers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFBiTWtVUlBZeHRyNE9Kc0dSVEJFWjBweFo3X2ZLZHB4V19JMk5tcUhISWhzbWVPdDJrenNnWGhqdm5jZUxhZlVjdGQxem12M3kyZ0syTml5anVwR0R2bkFUSi1EczVVMDJvNUNfdDVGakFRcnJjQUF4WFNIS0pBQQ?oc=5","date":"2026-02-02","type":"earnings","source":"China Daily","summary":"InnoCare Pharma posts 134% revenue surge in 2025, recording annual profit for first time - China Daily","headline":"InnoCare Pharma posts 134% revenue surge in 2025, recording annual profit for first time","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2026-01-26","type":"pipeline","source":"simplywall.st","summary":"Pinning Down InnoCare Pharma Limited's (HKG:9969) P/S Is Difficult Right Now - simplywall.st","headline":"Pinning Down InnoCare Pharma Limited's (HKG:9969) P/S Is Difficult Right Now","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-08","type":"deal","source":"globenewswire.com","summary":"Zenas BioPharma and InnoCare Pharma Announce License - globenewswire.com","headline":"Zenas BioPharma and InnoCare Pharma Announce License","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQNDk3N3J0am5IZGd2YkFVNjQ5YjhOVksxeG40MWZOWjdhR0JoWkdNWVhzdVlyTTltY2J1a0xsdktfQkZzSC1BbjBUc0lrUi1aN29NTzdYU05UUEJRRFhXQURzOEZjeVlHZmtZaGxfVTJ6TEtlbjNHam9BMm4tWWVBdU5VLWs3bWQxT2RnS1NMZU11ZjFENE5FZ2lHLWdHeHdDd2Ixck1GZw?oc=5","date":"2025-10-08","type":"pipeline","source":"BioPharma Dive","summary":"Zenas looks to China to stock pipeline with 3 more immune drugs - BioPharma Dive","headline":"Zenas looks to China to stock pipeline with 3 more immune drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOU1VfUnJXTE5fTUNGa1VoMk1oQzlWT28zRzdVUTkzaVJDYS1qbjh6VGlGSDZVRUdBWHRQakRqbUYxNmtCdTZ5N1VJOG5scVhnVWFRUThlS01yV3UxT3hZaHhwLUFIb1RaeTUyX0NuUXJPSURmS09OeGY1ck8tUF84T1JnS2NRMnoyYkFzbVNacGo3QzUtUHUweUEwVDR3Rm04?oc=5","date":"2025-10-08","type":"deal","source":"Fierce Pharma","summary":"Zenas makes big bet on MS drug, striking $2B licensing deal with InnoCare - Fierce Pharma","headline":"Zenas makes big bet on MS drug, striking $2B licensing deal with InnoCare","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxOcHRlT1lSSWxFZVFQWFhFRlFqcnFteFBiSnJjc3ZLMl9XUWRFcERwNVZheDNFZnJUTzNGWnVnSlJmYVJaUWpNTi1OX2EtTElkT2ZVYzhDSEJpRmVFdmMySmlaU1lrZ296V1RqUVhYZlpxWW5SUUtaT0pubENwbUZVV2JtYWY0aEhnUGpSMmE5UXh6Sl9FY3BDQy1jVUJyeWJzYW40akdRMVJCOGxuRHM3QUE0N0ZrVHUyMlhuOTNfdUhzQmVURUR6d2JuVTluemxpRkxaSmxudjFjdw?oc=5","date":"2025-10-08","type":"deal","source":"reuters.com","summary":"Zenas Bio inks potential $2 billion licensing deal with China's InnoCare for autoimmune drug - reuters.com","headline":"Zenas Bio inks potential $2 billion licensing deal with China's InnoCare for autoimmune drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQLWlsaHN1clBVTFUxNXRPZDhYckUtQUpyYlJuYVV4TVNNOHhNRFFHRGFZalB1blQwSkdLVVd1OVpkVmh5bkhlYTFBMkRCZHFxTEhsWndTQzRjbko3dkhCUkd6WFdRc0JMTVA5YVEzV1dJWEd5VW9QZ1RFUm4zZThlSHVFcENKZjM3a0djVUJObDc1cVNia0lOOWZFTnUzQVNDbWVHX2owZ0hQTEpPeHpsS2Vsdw?oc=5","date":"2025-10-08","type":"deal","source":"The Pharma Letter","summary":"Zenas inks license agreement with InnoCare for 3 autoimmune programs - The Pharma Letter","headline":"Zenas inks license agreement with InnoCare for 3 autoimmune programs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE1CQVFTZGMyU0FjZHF2cEZTTXo4R2FqUlZ5WmFaZXF5Z25Na0hqdEpTWnJDcmtIYVV4ajRRVS1xamRMVGNHVGFCc3JKM09yNmVCamZWVGtxTG8xZkpfbEh2RWY3b094ampzTEFvd2lIU0FESVNlc3ZnRHZEOA?oc=5","date":"2025-04-28","type":"regulatory","source":"Pharmaceutical Technology","summary":"China approves InnoCare Pharma’s BTK inhibitor for lymphoma - Pharmaceutical Technology","headline":"China approves InnoCare Pharma’s BTK inhibitor for lymphoma","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}